Cheonan, South Korea

Dong-Sik Jung

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Oscotec Inc., Genosco, Oscotech Inc.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong-Sik Jung. Retrieved from https://idiyas.com/inventor/dong-sik-jung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

 

 

Average Co-Inventor Count = 8.8

ph-index = 1


Location History:

  • Cheonan, KR (2015)
  • Cheonan-si, KR (2014 - 2022)
  • Seongnam-si, KR (2023)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Work of Dong-Sik Jung

Introduction

Dong-Sik Jung, a notable inventor based in Cheonan-si, South Korea, has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Jung's inventive work primarily focuses on developing novel compounds that address critical health issues.

Latest Patents

Among his latest patents is the "Crystal polymorph of 8-bromo-2-(1-methylpiperidin-4-ylamino)-4-(4-phenoxyphenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one hydrochloride and method for preparing same." This patent describes a crystal polymorph that effectively suppresses FLT3, exhibiting remarkable stability even under high temperature and humidity conditions. Another significant patent is for "Substituted pyrazoles as LRRK2 inhibitors." This invention includes a pyrrolo(pyrazolo)pyrimidine compound that demonstrates excellent inhibitory activity against LRRK2, along with pharmaceutical compositions and methods for treating or preventing degenerative brain diseases employing the compound.

Career Highlights

Dong-Sik Jung has an impressive career with experience in various prominent pharmaceutical companies. Notably, he has worked with Oscotec Inc. and Genosco, where he contributed to the advancement of novel therapeutic agents through his innovative research and development efforts.

Collaborations

Throughout his career, Jung has collaborated with talented professionals in the field, including colleagues Se-Won Kim and Jung-Ho Kim. These collaborations have likely enriched his research and fostered the development of impactful pharmaceutical inventions.

Conclusion

Dong-Sik Jung stands out as a dedicated inventor whose work is at the forefront of pharmaceutical innovation. His patents highlight his commitment to developing effective medical treatments, showcasing the potential for his inventions to positively impact health outcomes. With ongoing research and future endeavors, Jung continues to contribute to advancements in medicine and pharmacology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…